[Federal Register Volume 61, Number 219 (Tuesday, November 12, 1996)]
[Notices]
[Pages 58078-58079]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-28803]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Public Health Service


National Institutes of Health; Statement of Organization, 
Functions, and Delegations of Authority

    Part H, Chapter HN (National Institutes of Health) (NIH) of the 
Statement of Organization, Functions, and Delegations of Authority for 
the Department of Health and Human Services (40 FR 22859, May 27, 1975, 
as amended most recently at 61 FR 42433, August 15, 1996), is amended 
to reflect a reorganization within the National Institute of 
Neurological Disorders and Stroke (NINDS) (HNQ). The reorganization 
consists of the following: (1) Transfer the functions of the Division 
of Demyelinating, Atrophic, and Dementing Disorders (DDADD) (HNQ9) 
relating to neurodegenerative disease to the Division of Stroke and

[[Page 58079]]

Trauma (DST) (HNQ6), transfer the remaining functions of the DDADD 
relating to AIDS, multiple sclerosis and autoimmune disorders to the 
Division of Convulsive, Developmental and Neuromuscular Disorders 
(HNQ8), transfer the neural prostheses program activities from the 
Division of Fundamental Neurosciences (HNQ3) to the DST, retitle DST to 
the Division of Stroke, Trauma, and Neurodegenerative Disease, and 
revise its functional statement; (2) abolish the Division of 
Demyelinating, Atrophic, and Dementing Disorders (HNQ9); (3) transfer 
the functions of the Developmental Neurology Branch (DNB) of the 
Division of Convulsive, Developmental, and Neuromuscular Disorders 
(HNQ83) related to developmental neurobiology, developmental disorders 
and neurogenetics to the Division of Fundamental Neurosciences (DFN) 
(HNQ3), transfer the remaining functions of the DNB related to pain and 
neuromuscular disorders to the Office of the Director of the Division 
of Convulsive, Developmental, and Neuromuscular Disorders (HNQ8), 
retitle the DFN to the Division of Fundamental Neuroscience and 
Developmental Disorders, and revise its functional statement; (4) 
abolish the Developmental Neurology Branch of the Division of 
Convulsive, Developmental, and Neuromuscular Disorders (HNQ83); and (5) 
retitle the Division of Convulsive, Developmental, and Neuromuscular 
Disorders (HNQ8) to the Division of Convulsive, Infectious, and Immune 
Disorders and revise its functional statement.
    Section HN-B, Organization and Functions, is amended as follows: 
Under the heading National Institute of Neurological Disorders and 
Stroke (HNQ), (1) delete the titles and functional statements in their 
entirety for the Division of Demyelinating, Atrophic, and Dementing 
Disorders (HNQ9) and Developmental Neurology Branch (HNQ83); (2) delete 
the titles and functional statements in their entirety for the Division 
of Fundamental Neurosciences (HNQ3), Division of Stroke and Trauma 
(HNQ6), and Division of Convulsive, Developmental, and Neuromuscular 
Disorders (HNQ8) and substitute the following:

Division of Fundamental Neuroscience and Developmental Disorders (HNQ3)

    (1) Plans and directs a program of grant and contract support for 
research and research career development for fundamental cellular, 
molecular and systems neuroscience, for developmental neurobiology, for 
developmental disorders, and for neurogenetics to assure maximum 
utilization of available resources in the attainment of Institute 
objectives; (2) maintains surveillance over developments in these 
program areas and assesses the national need for research, including 
research on the cause, prevention, diagnosis, and treatment of 
developmental disorders, and pursues technological development, the 
application of research findings, and research training and career 
development in these areas; (3) determines program priorities and 
recommends funding levels for programs to be supported by grants; (4) 
determines priorities and funding levels for programs to be supported 
by contracts; (5) collaborates NIH-wide on national research efforts 
related to these program areas; (6) prepares reports and analyses of 
national needs to assist Institute staff and advisory groups in 
carrying out their responsibilities and in developing new areas of 
emphasis; and (7) consults with voluntary health organizations and with 
professional associations in identifying research needs and developing 
programs to meet these needs.

Division of Stroke, Trauma, and Neurodegenerative Disease (HNQ6)

    (1) Plans and directs a program of grant and contract support for 
research and research career development on stroke, on traumatic injury 
to the brain and nervous system, including traumatic brain and spinal 
cord injury, on neurodegenerative disorders, including parkinson's 
disease and alzheimer's disease, on brain tumors and on the development 
of artificial prosthetic devices to restore function to the damaged 
nervous system to assure maximum utilization of available resources in 
the attainment of Institute objectives; (2) maintains surveillance over 
developments in these program areas and assesses the national need for 
research in the cause, prevention, diagnosis, and treatment of 
convulsive, infectious and immune disorders of the brain and the 
nervous system, and pursues technological development, the application 
of research findings, and research training and career development in 
these areas; (3) determines program priorities and recommends funding 
levels for programs to be supported by grants; (4) determines 
priorities and funding levels for programs to be supported by 
contracts; (5) collaborates NIH-wide on national research efforts 
related to these program areas; (6) prepares reports and analyses of 
national needs to assist Institute staff and advisory groups in 
carrying out their responsibilities and in developing new areas of 
emphasis; and (7) consults with voluntary health organizations and with 
professional associations in identifying research needs and developing 
programs to meet these needs.

Division of Convulsive, Infectious, and Immune Disorders (HNQ8)

    (1) Plans and directs a program of grant and contract support for 
research and research career development on convulsive disorders, 
including epilepsy, infectious disorders of the brain and the nervous 
system, including AIDS, immune disorders of the brain and the nervous 
system, including multiple sclerosis, disorders related to the sleep 
mechanisms, and pain to assure maximum utilization of available 
resources in the attainment of Institute objectives; (2) maintains 
surveillance over developments in these program areas and assesses the 
national need for research in the cause, prevention, diagnosis, and 
treatment of convulsive, infectious and immune disorders of the brain 
and the nervous system, and pursues technological development, the 
application of research findings, and research training and career 
development in these areas; (3) determines program priorities and 
recommends funding levels for programs to be supported by grants; (4) 
determines priorities and funding levels for programs to be supported 
by contracts; (5) collaborates NIH-wide on national research efforts 
related to these program areas; (6) prepares reports and analyses of 
national needs to assist Institute staff and advisory groups in 
carrying out their responsibilities and in developing new areas of 
emphasis; and (7) consults with voluntary health organizations and with 
professional associations in identifying research needs and developing 
programs to meet these needs.

    Dated: October 31, 1996.
Harold Varmus,
Director, NIH.
[FR Doc. 96-28803 Filed 11-8-96; 8:45 am]
BILLING CODE 4140-01-M